TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.3080
0.00 (0.00%)
Sep 3, 2025, 4:00 PM EDT
TC Biopharm (Holdings) Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 1.22 | 2.46 | 4.81 | 1.57 | 0.75 | Upgrade |
Cash & Short-Term Investments | 1.22 | 2.46 | 4.81 | 1.57 | 0.75 | Upgrade |
Cash Growth | -50.64% | -48.78% | 206.89% | 109.45% | -21.80% | Upgrade |
Other Receivables | 0.66 | 1.1 | 1.78 | 1.41 | 1.18 | Upgrade |
Receivables | 0.66 | 1.1 | 1.78 | 1.41 | 1.18 | Upgrade |
Prepaid Expenses | 0.79 | 0.83 | 0.84 | 0.81 | 0.23 | Upgrade |
Other Current Assets | 3.11 | 1.31 | 0.03 | 0.07 | 0.05 | Upgrade |
Total Current Assets | 5.77 | 5.7 | 7.45 | 3.86 | 2.22 | Upgrade |
Property, Plant & Equipment | 2.09 | 2.62 | 3.29 | 3.68 | 4.63 | Upgrade |
Other Intangible Assets | 0.47 | 0.62 | 0.55 | 0.48 | 0.42 | Upgrade |
Total Assets | 8.33 | 8.93 | 11.29 | 8.02 | 7.27 | Upgrade |
Accounts Payable | 1.39 | 1.85 | 0.88 | 1.42 | 0.64 | Upgrade |
Accrued Expenses | 2.19 | 2.41 | 0.94 | 2.33 | 0.92 | Upgrade |
Short-Term Debt | - | - | 0.65 | 13.73 | - | Upgrade |
Current Portion of Leases | 0.33 | 0.31 | 0.33 | 0.77 | 0.44 | Upgrade |
Current Income Taxes Payable | 0.24 | 0.14 | 0.29 | 0.31 | 0.14 | Upgrade |
Current Unearned Revenue | - | - | - | 1.98 | 1.98 | Upgrade |
Other Current Liabilities | 0 | 0.05 | 6.06 | 0.04 | 0.06 | Upgrade |
Total Current Liabilities | 4.15 | 4.75 | 9.16 | 20.58 | 4.19 | Upgrade |
Long-Term Leases | 1.17 | 1.5 | 1.8 | 2.14 | 2.58 | Upgrade |
Long-Term Unearned Revenue | - | - | - | 1.87 | 3.84 | Upgrade |
Total Liabilities | 5.32 | 6.25 | 10.96 | 24.58 | 10.61 | Upgrade |
Common Stock | 0.65 | 0.4 | 0.4 | 0.2 | 0.19 | Upgrade |
Additional Paid-In Capital | 54.92 | 42.69 | 33.31 | - | - | Upgrade |
Retained Earnings | -52.56 | -40.4 | -33.37 | -33.47 | -19.89 | Upgrade |
Comprehensive Income & Other | - | - | - | 16.71 | 16.35 | Upgrade |
Shareholders' Equity | 3.01 | 2.69 | 0.33 | -16.56 | -3.35 | Upgrade |
Total Liabilities & Equity | 8.33 | 8.93 | 11.29 | 8.02 | 7.27 | Upgrade |
Total Debt | 1.5 | 1.8 | 2.78 | 16.63 | 3.03 | Upgrade |
Net Cash (Debt) | -0.28 | 0.66 | 2.03 | -15.07 | -2.28 | Upgrade |
Net Cash Growth | - | -67.41% | - | - | - | Upgrade |
Net Cash Per Share | -3.01 | - | - | - | - | Upgrade |
Filing Date Shares Outstanding | 2.1 | 0.02 | - | - | - | Upgrade |
Total Common Shares Outstanding | 0.64 | - | - | - | - | Upgrade |
Working Capital | 1.63 | 0.95 | -1.72 | -16.72 | -1.97 | Upgrade |
Book Value Per Share | 4.72 | - | - | - | - | Upgrade |
Tangible Book Value | 2.54 | 2.07 | -0.22 | -17.04 | -3.77 | Upgrade |
Tangible Book Value Per Share | 3.99 | - | - | - | - | Upgrade |
Machinery | 0.49 | 0.45 | 0.43 | 0.42 | 0.41 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.